A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease

PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 16, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

September 30, 2026

Conditions
Chronic Kidney DiseaseRenal Anemia
Interventions
DRUG

Roxadustat

Oral

Trial Locations (45)

8200

RECRUITING

Site DK45001, Aarhus

28041

RECRUITING

Site SP34001, Madrid

30011

RECRUITING

Site RO40001, Timișoara

400370

RECRUITING

Site RO40002, Clug Napoca

Unknown

RECRUITING

Site BE32002, Brussels

RECRUITING

Site BE32001, Edegem

RECRUITING

Site BE32004, Ghent

RECRUITING

Site BE32003, Leuven

RECRUITING

Site BG35901, Sofia

RECRUITING

Site HR38501, Zagreb

RECRUITING

Site HR38503, Zagreb

RECRUITING

Site CZ42002, Brno

RECRUITING

Site CZ42001, Prague

RECRUITING

Site DE49001, Tübingen

RECRUITING

Site GR30002, Athens

RECRUITING

Site GR30001, Thessaloniki

RECRUITING

Site IE35301, Dublin

RECRUITING

Site IT39003, Milan

RECRUITING

Site LB96101, El Achrafiyé

RECRUITING

Site LT37001, Vilnius

RECRUITING

Site NL31002, Rotterdam

RECRUITING

Site NO47002, Oslo

RECRUITING

Site PL48003, Krakow

RECRUITING

Site PL48002, Warsaw

RECRUITING

Site SA96602, Dammam

RECRUITING

Site SA96601, Riyadh

RECRUITING

Site SK42101, Bratislava

RECRUITING

Site ES34003, Esplugues de Llobregat

RECRUITING

Site SE46002, Mölnlycke

RECRUITING

Site SE46003, Mölnlycke

RECRUITING

Site TR90001, Ankara

RECRUITING

Site TR90007, Ankara

RECRUITING

Site TR90010, Ankara

RECRUITING

Site TR90003, Istanbul

RECRUITING

Site TR90008, Istanbul

RECRUITING

Site TR90005, İzmit

RECRUITING

Site TR90006, Kayseri

RECRUITING

Site TR90002, Manisa

RECRUITING

Site GB44005, Cardiff

RECRUITING

Site GB44006, Glasgow

RECRUITING

Site GB44008, Liverpool

RECRUITING

Site GB44007, London

RECRUITING

Site GB44003, Newcastle upon Tyne

RECRUITING

Site GB44001, Nottingham

RECRUITING

Site GB44004, Southampton

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT05970172 - A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease | Biotech Hunter | Biotech Hunter